{"entity":{"id":"nct02448173","kind":"trial","name":"A Multicenter Study of Active Specific Immunotherapy With OncoVax® in Patients With Stage II Colon Cancer","aka":[],"tldr":"A phase 3 trial in colorectal cancer, run by Vaccinogen Inc, not yet recruiting.","summary":"A Multicenter Study of Active Specific Immunotherapy With OncoVax® in Patients With Stage II Colon Cancer is a phase 3, randomised interventional study registered as NCT02448173 by Vaccinogen Inc, with a registry enrolment figure of 550 participants, started 2026-08 and due to reach its primary completion in 2031-08. Interventions recorded: OncoVAX and Surgery; Surgery. Conditions listed: Stage II Colon Cancer. Primary outcome: Disease-Free Survival. Colorectal eligibility wording from the registry: \"* Patients with more than one malignant primary colon cancer will be excluded\". Sites: United States. No results are recorded here; the registry entry is the source.","status":"planned","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT02448173","url":"https://clinicaltrials.gov/study/NCT02448173"}],"tags":["ctgov-ingest","colorectal-deep-dive"],"related":[],"cancers":["colon-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT02448173","phase":"3","setting":"A Randomized Multicenter Study of Active Specific Immunotherapy With OncoVax® in Patients With Stage II Colon Cancer","sponsor":"Vaccinogen Inc","enrolled":550,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct02448173/","neighbours":{"cancer":[{"id":"colon-cancer","kind":"cancer","name":"Colon cancer (adenocarcinoma of the colon)","route":"/cancers/colon-cancer/"}],"term":[{"id":"colorectal-trials-open-today","kind":"term","name":"Colorectal cancer trials open today (registry snapshot)","route":"/terms/colorectal-trials-open-today/"}]}}